Critical Illness — Brain Computer Interface for Communication in Ventilated Patients
Citation(s)
Baker C, Melby V An investigation into the attitudes and practices of intensive care nurses towards verbal communication with unconscious patients. J Clin Nurs. 1996 May;5(3):185-92.
Brunner P, Bianchi L, Guger C, Cincotti F, Schalk G Current trends in hardware and software for brain-computer interfaces (BCIs). J Neural Eng. 2011 Apr;8(2):025001. doi: 10.1088/1741-2560/8/2/025001. Epub 2011 Mar 24. Review.
Carroll SM Nonvocal ventilated patients perceptions of being understood. West J Nurs Res. 2004 Feb;26(1):85-103; discussion 104-12. Review.
Chaudhary U, Birbaumer N, Curado MR Brain-machine interface (BMI) in paralysis. Ann Phys Rehabil Med. 2015 Feb;58(1):9-13. doi: 10.1016/j.rehab.2014.11.002. Epub 2015 Jan 8.
Daly JJ, Huggins JE Brain-computer interface: current and emerging rehabilitation applications. Arch Phys Med Rehabil. 2015 Mar;96(3 Suppl):S1-7. doi: 10.1016/j.apmr.2015.01.007.
Herrmann CS Human EEG responses to 1-100 Hz flicker: resonance phenomena in visual cortex and their potential correlation to cognitive phenomena. Exp Brain Res. 2001 Apr;137(3-4):346-53.
Johnson MM, Sexton DL Distress during mechanical ventilation: patients' perceptions. Crit Care Nurse. 1990 Jul-Aug;10(7):48-57. Erratum in: Crit Care Nurse 1990 Sep;10(8):72.
Marchetti M, Priftis K Brain-computer interfaces in amyotrophic lateral sclerosis: A metanalysis. Clin Neurophysiol. 2015 Jun;126(6):1255-1263. doi: 10.1016/j.clinph.2014.09.017. Epub 2014 Oct 2.
Sellers EW, Ryan DB, Hauser CK Noninvasive brain-computer interface enables communication after brainstem stroke. Sci Transl Med. 2014 Oct 8;6(257):257re7. doi: 10.1126/scitranslmed.3007801.
Smith E, Delargy M Locked-in syndrome. BMJ. 2005 Feb 19;330(7488):406-9. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
